Cumberland Pharmaceuticals Inc (CPIX): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2017-12-31, 2018-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

14.96M
As of 2025-12-31
14.98M
As of 2026-06-30
+1.4%
3-year compound annual growth
0.0%
5-year compound annual growth
20.34M2010-12-31: 20.34M2011-12-31: 20.02M2012-12-31: 18.94M2013-12-31: 17.99M2014-12-31: 17.12M2015-12-31: 16.38M2016-12-31: 16.07M2017-12-31: 16.07M2018-12-31: 15.48M2019-12-31: 15.26M2020-12-31: 14.99M2021-12-31: 14.74M2022-12-31: 14.37M2023-12-31: 14.12M2024-12-31: 13.95M2025-12-31: 14.96M14.96M
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3114.96M+7.2%2026-03-09, Balance as of period end
2024-12-3113.95M-1.2%2026-03-09, Balance as of period end
2023-12-3114.12M-1.7%2025-03-07, Balance as of period end
2022-12-3114.37M-2.6%2024-03-13, Balance as of period end
2021-12-3114.74M-1.6%2023-03-13, Balance as of period end
2020-12-3114.99M-1.8%2022-03-11, Balance as of period end
2019-12-3115.26M-1.4%2021-03-12, Balance as of period end
2018-12-3115.48Mn/c2020-03-20, Balance as of period end
2017-12-3116.07Mn/c2019-03-12, Balance as of period end
2016-12-3116.07M-1.9%2018-03-09, Balance as of period end
2015-12-3116.38M-4.3%2017-03-13, Balance as of period end
2014-12-3117.12M-4.8%2016-03-14, Balance as of period end
2013-12-3117.99M-5.0%2015-03-09, Balance as of period end
2012-12-3118.94M-5.4%2014-03-11, Balance as of period end
2011-12-3120.02M-1.6%2012-03-07, Balance as of period end
2010-12-3120.34Mn/a2012-03-07, Balance as of period end